A case of isolated intraocular recurrence of acute lymphoblastic leukemia

Cover Page

Cite item

Full Text

Abstract

The development of diagnostic and therapeutic capabilities in hematology contributed to a growth in survival rate in patients with acute leukemia and to the increase in number of different ocular conditions as rare signs of hemoblastosis recurrence and treatment’s side effects. We observed a female patient with extramedullar leukemic ocular damage in acute lymphoblastic leukemia. It is noteworthy that the process of ocular involvement into the underlying disease occurred on the background of complete confirmed hematologic remission.

About the authors

Natalia V. Chistyakova

Scientific Research Institution of Pediatric Oncology, Hematology and Trasplantology n.a. R.M. Gorbacheva clinic

Author for correspondence.
Email: shadrichev_dr@mail.ru

MD, candidate of medical sciences, ophthalmologist

Russian Federation, Saint Petersburg

Fedor E. Shadrichev

St. Peterburg territorial diabetology center

Email: shadrichev_dr@mail.ru

MD, candidate of medical sciences, head of the ophthalmology department

Russian Federation, Saint Petersburg

Tatiana I. Kuznetsova

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: brionika@gmail.com

MD, ophthalmologist

Russian Federation, Saint Petersburg

References

  1. Alemayehu W, Shamebo M, Bedri A, Mengistu Z. Ocular manifestations of leukaemia in Ethiopians. Ethiop Med J. 1996;34:217-224.
  2. Allan R.A, Straatsma BR. Ocular involvement in leukaemIa and allied disorders. Arch Ophthalmol. 1961;66:490-508. doi: 10.1001/archopht.1961.00960010492010.
  3. Allen RA, Straatsma BR. Ocular involvement in leukaemia and allied disorders. Arch Ophthalmol. 1961;66:490-508. doi: 10.1001/archopht.1961.00960010492010.
  4. Ayliffe W, Foster CS, Marcoux P, et al. Relapsing acute myeloid leukaemia manifesting as hypopyon uveitis. Am J Ophthalmol. 1995;119:361-364. doi: 10.1016/S0002-9394(14)71181-X.
  5. Bunin N, Rivera G, Goode F, Hustu HO. Ocular relapse in the anterior chamber in childhood acute lymphoblastic leukaemia. Clin Oncol. 1987;5:299-303. doi: 10.1200/JCO.1987.5.2.299.
  6. Curto ML, D'Angelo P, Jankovic M, et al. Isolated Ocular Relapse In Childhood Acute Lymphoblastic Leukemia During Continuing Complete Remission. Haematologica. 1996;81:47-50.
  7. Ellis W, Little HL. Leukaemic infiltration of the optic nerve head. Am J Ophthalmol. 1973;75:867-871. doi: 10.1016/0002-9394(73)90893-3.
  8. Feng S, Huang Y, Chen Z. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia. Med Hypotheses. 2011;76(5):618-21. doi: 10.1016/j.mehy.2010.12.001.
  9. Fonken HA, Ellis PP. Leukaemic infiltrates in the iris. Arch Ophthalmol. 1966;76:32-36. doi: 10.1001/archopht.1966.03850010034009.
  10. Frank RN, Ryan Jr SJ. Peripheral retinal neovascularistation with chronic myelogenous leukaemia. Arch Ophthalmol. 1972;87:585-589. doi: 10.1001/archopht.1972.01000020587017.
  11. Garrido Colino C, Mateos Gonzalez M, Torres Valdivieso M, et al. Ocular infiltration in the anterior chamber in a female infant with acute non-lymphoblastic leukaemia. Anales Espanoles de Pediatria. 2001;55:69-72. doi: 10.1016/S1695-4033(01)77629-1.
  12. Jampol LM, Goldberg MF, Busse B. Peripheral retinal micro aneurysms in chronic leukaemia. Am J Ophthalmol. 1975;80:242-248. doi: 10.1016/0002-9394(75)90139-7.
  13. Jankovic M, Conter V, Pretto G, et al. Isolated bilateral anterior chamber eye relapse in a child with acute lymphoblastic leukaemia. Med Pediatr Oncol. 1995;25:109-112. doi: 10.1002/mpo.2950250211.
  14. Kincaid MC, Green WR. Ocular and orbital involvement in leukaemia. Surv OphthalmoI. 1983;27:211-32.
  15. Kuwabara T, Aiello L. Leukaemic military nodule in retina. Arch Ophthalmol. 1964;72:494-497. doi: 10.1001/archopht.1964.00970020494010.
  16. MacLean H, Clarke MP, Strong NP, Kernahan J. Primary relapse of acute leukaemia in anterior segment of the eye. Lancet. 1995;346:500. doi: 10.1016/S0140-6736(95)91347-5.
  17. Martin B. Infiltration of the iris in chronic lymphatic leukaemia. Br J Ophthalmol. 1968;52:781-785. doi: 10.1136/bjo.52.10.781.
  18. Masera G, Carnelli V, Uderzo C, et al. Ocular involvement in leukaemia: Report of three cases. Lancet. 1977;1:829-831.
  19. Newman NM, Smith ME, Gay AJ. An unusual case of leukaemia involving the eye: a clinico-pathological study. Surv Ophthalmol. 1972;16:316-321.
  20. Ninane J, Taylor D, Day S. Leukaemic hypopyon in acute lymphoblastic leukaemia after interruption of treatment. Arch Dis Child. 1979;54:73-74. doi: 10.1136/adc.54.1.73.
  21. Ninane J, Taylor D, Pay S. The eyes as a sanctuary site in acute lymphoblastic leukaemia. Lancet. 1980;1:452-3. doi: 10.1016/S0140-6736(80)90999-X.
  22. Ohkoshi K, Tsiaras WG. Prognostic importance of ophthalmic manifestations in childhood leukaemia. Br J Ophthalmol. 1992;76:651-655. doi: 10.1136/bjo.76.11.651.
  23. Primack JD, Smith ME, Tychsen L, et al. Retinal detachment in a child as the first sign of leukemic relapse. J Pediatr Ophthalmol Strabismus. 1995;32:253-256.
  24. Ridgeway EW, Jaffe N, Walton DS. Leukaemic ophthalmopathy in children. Cancer. 1976;38:1744-9. doi: 10.1002/1097-0142(197610)38:4<1744::AID-CNCR2820380449>3.0.CO;2-3.
  25. Rowan PJ, Sloan JB. Iris and Anterior chamber involvement in leukaemia. Ann Ophthalmol. 1976;8:1081-1085.
  26. Wetzler M. Unusual manifestations of acute leukemia. Case 3. Unilateral leukemic hypopyon. J Clin Oncol. 2000;18(19):3439-40. doi: 10.1200/JCO.2000.18.19.3439.
  27. Wolintz AH, Goldstein JH, Seligman BR, et al. Secondary glaucoma in leukaemia. Ann Ophthalmol. 1971;3:1211-1213.
  28. Yi DH, Rashid S, Cibas ES, et al. Acute unilateral leukemic hypopyon in an adult with relapsing acute lymphoblastic leukemia. Am J Ophthalmol. 2005;139:719-21. doi: 10.1016/j.ajo.2004.09.074.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Chistyakova N.V., Shadrichev F.E., Kuznetsova T.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies